Loading company…
Tyra Biosciences, Inc., based in Carlsbad, US, is a biotech company developing therapeutics that target drug-resistant cancer cells.
Founded in 2018 by CEO and co-founder Daniel Bensen and Todd Harris, Tyra Biosciences, Inc. develops inhibitors that re-sensitize cancer cells to platinum-based chemotherapy by targeting a newly identified protein. Its shares began trading on Nasdaq on September 15, 2021, under the ticker TYRA. In February 2024 it raised USD 200 million in PIPE funding led by RA Capital Management, and it plans to use the funds to expand its SNAP drug discovery platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in